AAR Corp, Arbutus Biopharma, and AMC see significant market shifts

Several companies saw notable market activity. AAR Corp shares declined by 7.06% despite reporting first-quarter fiscal year 2027 earnings that exceeded expectations. The decline follows the announcement that AAR will acquire a 65% controlling interest in MRO Holdings for an implied enterprise value of $4 billion. To finance this acquisition, AAR plans to issue $2.1 billion in new debt and $780 million in equity.

Arbutus Biopharma Corporation (ABUS) saw its stock rise 5.3% during mid-day trading. While the company recently reported quarterly revenue of $1.01 million, exceeding analyst estimates, its earnings per share of ($0.03) slightly missed consensus expectations. The stock currently holds a consensus rating of “Moderate Buy” with an average target price of $5.00.

On the Robinhood on-chain platform, AMC Entertainment saw its 24-hour trading volume surge sixfold to $5.65 million. Additionally, the Cash Cat (CASHCAT) token experienced a ninefold increase in trading volume.